Intel Corporation (NASDAQ:INTC) is set to launch the E Chip and X99 chip in late August. This report comes from Japanese tech website Hermitage Akihabara, which received this information from several officials. The report also mentioned the company will unveil X99 Express chip.
A look at Intel’s new chips
It was noted manufacturers are preparing for new CPUs and motherboards, both of which are said to be as numerous as the predecessors for Intel’s Z97. Previously, two Intel X99 chipset motherboards from EVGA were revealed by Guru 3D. The images display mATX ($250.00) and ATX Classified ($400) motherboards. The former features three PCI-Express 3.0 x16 slots, four DIMM slots, M.2 storage connector, and six SATA3 6Gbps ports.
Coho Capital 2Q20 Commentary: Podcasts, The New Talk Radio
Coho Capital commentary for the second quarter ended June 30, 2020. Q2 2020 hedge fund letters, conferences and more Dear Partners, Coho Capital returned 46.6% during the first half of the year compared to a loss of 3.1% in the S&P 500. Many of our holdings, such as Netflix, Amazon, and Spotify, were perceived beneficiaries Read More
The Classified version comes with five PCI-Express 3.0 x 16 slots, one X4 slot, eight DIMM slots, two M.2 storage connectors, and 10 SATA3 6Gbps ports. Just last week, computer maker Lenovo unveiled three new P Series ThinkStation desktop workstations that feature Haswell E Xeon.
Intel contributes to science research
In other Intel related news, the chip maker plans to apply big data into medicine. The company wants to pair up analytics software with smartwatches for big data. Intel also joined forces with the Michael J Fox Foundation in efforts to conduct a study. This particular project will use data from wearable devices to detect disease progression patterns. It will include 25 Parkinson’s patients who initially signed up to wear a Pebble smartwatch.
The watch will detect patterns in sleep, movement slowness, and tremors. Intel’s watch software will collect key data from the smartwatches and researchers will be able to examine the markers of the disease, something that cannot be seen with a naked eye.
The Michael J. Fox Foundation also hopes to enroll about a thousand more participants in the study so it can be compared to the control group.